Drug-coated balloons (DCBs), made with either sirolimus or paclitaxel, are often used to treat coronary artery disease. Researchers at CVPath investigated the vascular and downstream effects and drug pharmacokinetics in a porcine coronary model treated with three different types of DCBs, as well as plain old balloon angioplasty (POBA).?
CVPath Institute, Inc.
研究服务
Gaithersburg，MD 618 位关注者
Discovering the Future of Cardiovascular Medicine
关于我们
CVPath Institute is the leading medical research and educational organization dedicated to improving patient health management for those suffering from cardiac and vascular diseases. Established in 2005 as a not-for-profit organization under section 501(c)(3) of the Internal Revenue Code, our mission is to conduct basic and translational “bench to bedside” research. We provide consultation, histology, and diagnostic services to promote discoveries that advance diagnosis and treatment of cardiovascular diseases. Additionally, the institution codifies one of the largest and most comprehensive repositories of diseased human tissue and makes it available for investigative studies and teaching.
- 网站
-
www.cvpath.org
CVPath Institute, Inc.的外部链接
- 所属行业
- 研究服务
- 规模
- 11-50 人
- 总部
- Gaithersburg，MD
- 类型
- 非营利机构
- 创立
- 2005
地点
-
主要
获取路线
19 Firstfield Road
US，MD，Gaithersburg，20878
CVPath Institute, Inc.员工
-
Aloke Finn
President and Chief Scientific Officer CVPath Institute Inc. Clinical Professor at University of Maryland School of Medicine
-
Antonisha Morrison
Executive Assistant at CVPath Institute, Inc.
-
Katherine Murphy, MS, PA (ASCP), ACRP-PM
Certified Pathologists’ Assistant | Project Manager | ASCP and ACRP Certified
-
Joe Burns
Lead Quality Assurance Specialist